Your Thyroid Problem Is Actually A Conversion Problem

Your thyroid makes a hormone called T4, which is essentially an inactive storage form, and then your body converts that T4 into T3, which is the version your cells can actually use to regulate metabolism, energy, temperature, and dozens of other functions. The thyroid produces it, but the conversion happens somewhere else entirely, and that gap between production and activation is where most thyroid problems actually live.

The full chain looks like this. Your hypothalamus signals your pituitary, your pituitary releases something called TSH, which stands for thyroid stimulating hormone, and TSH tells your thyroid how much T4 to make. Your thyroid makes T4, ships it into the bloodstream, and then your liver, kidneys, and muscle tissue convert that T4 into active T3 using enzymes called deiodinases, which are proteins that strip one iodine atom off the T4 molecule to activate it. The T3 then enters your cells, binds to receptors in the nucleus, and directly switches genes on or off. That is the whole system.

Most doctors are measuring TSH and stopping there.

TSH tells you what the pituitary is doing. It does not tell you whether the conversion is working, whether T3 is reaching your cells, or whether something downstream is breaking the chain. Current American Thyroid Association guidelines recommend TSH as the primary monitoring tool and do not call for routine measurement of free T3 or reverse T3, which means the standard of care is measuring one control signal while ignoring what actually gets delivered.

A 2011 study published in PLoS ONE looked at patients with no thyroid at all who were on levothyroxine, which is synthetic T4, and found that more than 20 percent of them had abnormal free T3 or free T4 levels even when their TSH appeared completely normal. Their pituitary was satisfied. Their cells were not getting the hormone. These are two different things, and TSH alone cannot tell them apart.

Here is where the conversion piece gets specific. Between 70 and 90 percent of active T3 in your body is not made by your thyroid. It is made in peripheral tissue through a conversion process driven by those deiodinase enzymes. The liver and kidneys carry an enzyme called D1 deiodinase, and skeletal muscle carries D2 deiodinase, and together these tissues are responsible for the majority of your circulating active thyroid hormone. Your thyroid is the supplier of raw material, but your body's own tissue is the manufacturer.

This means the amount of muscle you carry is not just about strength or appearance. It is literally about how much manufacturing capacity you have for active thyroid hormone.

Several things can break this conversion. Chronic stress elevates cortisol, and high cortisol suppresses deiodinase activity, so the raw material sits in circulation as T4 but never becomes T3. Low protein intake limits the amino acid availability your body needs to run these enzymatic processes. Low selenium is a direct bottleneck because deiodinase enzymes are selenoproteins, meaning selenium is structurally part of the enzyme itself, and without enough of it the enzyme cannot function at normal capacity. Chronic inflammation, which is common in autoimmune thyroid conditions like Hashimoto's thyroiditis, also impairs conversion independently.

This is why some people feel terrible despite a TSH that their doctor calls normal.

A 2025 case report in Cureus documented a patient with Hashimoto's thyroiditis who underwent a structured high protein dietary intervention and saw resolution of symptoms alongside measurable improvement in thyroid antibody levels, and this is preliminary, a single case is not a clinical trial, but it illustrates the mechanism, which is that the substrate you give your body directly affects how well it can run thyroid hormone metabolism.

The exercise side of this has more data behind it. A 2025 cross sectional study in Biomolecules found that recreational exercise was associated with meaningfully lower inflammatory markers in Hashimoto's patients compared to sedentary controls, and since inflammation is one of the primary drivers of impaired T4 to T3 conversion, reducing inflammation through exercise is not just general health advice, it is directly targeting the conversion pathway.

So what actually moves the needle here before you ever consider a prescription?

Building muscle is the most mechanically direct intervention because more skeletal muscle means more D2 deiodinase capacity, which means more sites for T4 to become T3. Eating enough protein supports the enzymatic machinery that does the conversion. Managing sleep and chronic stress reduces cortisol, which removes one of the primary brakes on the conversion enzymes. Getting selenium through food, which is available in two or three Brazil nuts or through organ meats and seafood, ensures the enzymes have what they need to function. And getting a full thyroid panel, meaning TSH plus free T3, free T4, and reverse T3, gives you an actual picture of where in the chain the problem is.

Reverse T3 matters here because it is what happens when the conversion goes wrong in the other direction. Instead of T4 becoming active T3, it becomes something called reverse T3, which is a molecule that fits into the same cell receptors as T3 but does not activate them, which means it is essentially a competitive blocker of thyroid function at the cellular level, and it gets produced in higher amounts during high cortisol states, caloric restriction, and chronic illness.

If symptoms persist after addressing the lifestyle variables, the clinical evidence does support adding T3 directly. A 2022 study in Frontiers in Endocrinology found that adding liothyronine, which is synthetic T3, to levothyroxine therapy significantly improved quality of life scores in female patients who had residual symptoms despite normal TSH on T4 alone. The reason T3 addition helps where more T4 does not is that it bypasses the conversion step entirely and delivers the active hormone directly.

The standard framework assumes the thyroid is the whole story. Make more T4, TSH normalizes, problem solved. But T4 is not the active hormone. T3 is. And the system that turns one into the other is running in your muscle and your liver and your kidneys, powered by nutrients, regulated by cortisol, and built up or broken down by how you move and eat and sleep.

Treating a conversion problem with more raw material is not a solution. It is just more unfinished product.

---

References

1. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R. (2011). Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients. PLoS ONE 6(8):e22552. PMC3148220.
2. Cited for: the >20% of patients with abnormal FT3 or FT4 despite normal TSH on levothyroxine.
3. Limbaugh SL, Ennessy LA, Davis KS, Allen VT. (2025). Nutrition Based, High Protein Adjunct Therapy for Hashimoto's Thyroiditis: A Case Report. Cureus 17(9):e91597. PMC12495900.
4. Cited for: protein protocol resolving Hashimoto's symptoms.
5. Vuletić M, Žnidar V, Barić Žižić A, et al. (2025). Recreational Exercise and Inflammatory Patterns in Hashimoto's Thyroiditis: Observations from a Cross Sectional Study. Biomolecules 15(11):1510. PMC12650045.
6. Cited for: exercise reducing inflammatory markers in Hashimoto's patients.
7. Bjerkreim BA, Hammerstad SS, Gulseth HL, et al. (2022). Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy. Frontiers in Endocrinology 13:816566. PMC8902821.
8. Cited for: clinical evidence that adding T3 improves quality of life in patients with residual symptoms.
9. Lindner HH. (2025). Clinical thyroidology: beyond the 1970s' TSH T4 Paradigm. Frontiers in Endocrinology 16:1529791. PMC12234311.
10. Cited for: critique of the TSH only diagnostic model. Note: single author opinion piece.
11. European Thyroid Journal. Role of hepatic deiodinases in thyroid hormone homeostasis. PMC10160546.
12. Cited for: D1 distribution in liver and kidney, D2 distribution in skeletal muscle.
13. ScienceDirect Topics. Thyroxine Deiodinase.
14. Cited for: the 70-90 percent peripheral conversion figure.
15. Pituitary Foundation. Hormone Replacement Medication Interactions.
16. Cited for: thyroid hormone status affecting IGF-1 levels.
17. American Thyroid Association Guidelines on Treatment of Hypothyroidism.
18. Cited for: current guideline recommending TSH for monitoring without routine FT3 or rT3 testing.

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness